The Inscripta® Blog
November 22, 2022
Synthetic Biotics: The Biotherapeutics of The Future | Inscripta
Microbes play several key roles in human health. Since some microbes are pathogenic, a critical research focus is studying mechanisms of…
October 11, 2022
Your Favorite Library Series: Library 1: Genome-Wide Knockout (GWKO)
We’re kicking off a series of our favorite “library recipes” to showcase different library designs Inscripta scientists have created using the…
September 20, 2022
The White House Summit on Biotechnology and Biomanufacturing
Last week I was honored to represent Inscripta at the White House Summit on Biotechnology and Biomanufacturing. It was extremely encouraging to…
July 19, 2022
Inside Inscripta: Michael Gonzales
Successful marketing for a science company requires a special combination of skills. You need to possess a technical foundation to understand…
July 8, 2022
Deep mutational scanning of essential bacterial proteins can guide antibiotic development
It is estimated that nearly 5 million patients who die annually have at least one antimicrobial-resistant infection and these infections…
June 28, 2022
Inside Inscripta: Alex Hutcheson, Sales
At Inscripta our customers, both current and future, are everything. It takes the right combination of technical expertise and people skills to…
June 15, 2022
Why Is It Important To Talk About Diversity?
Every June we see a wave of color taking over social media, storefronts and even products. Companies change their logos to a rainbow version to…
June 7, 2022
Willow Biosciences Incorporates Inscripta’s Onyx® Platform to Expand its Strain Engineering Capabilities
Willow Bioscience, a leading biotech company that produces sustainable, bio-based ingredients, announced they have adopted Inscripta’s Onyx…
May 31, 2022
Inside Inscripta: Charlotte Cialek, Applications Development
Rolling out a transformative technology like the Onyx® platform for genome engineering requires great science, technical skills, and a lot of…